SEC Comment Letter 0000000000-24-010060 to Imunon, Inc. (IMNN)

Imunon, Inc.
Date: Sept. 5, 2024 · CIK: 0000749647 · Accession: 0000000000-24-010060

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-281834

Date

September 5, 2024

Author

Michael H. Tardugno

Form

UPLOAD

Company

Imunon, Inc.

Letter

September 5, 2024 Michael H. Tardugno Executive Chairman of the Board Imunon, Inc. 997 Lenox Drive, Suite 100 Lawrenceville, NJ 08648 Re:Imunon, Inc. Registration Statement on Form S-1 Filed August 29, 2024 File No. 333-281834 Dear Michael H. Tardugno: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Daniel Crawford at 202-551-7767 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:KJ Cho, Esq.

Show Raw Text

September 5, 2024
Michael H. Tardugno
Executive Chairman of the Board
Imunon, Inc.
997 Lenox Drive, Suite 100
Lawrenceville, NJ 08648
Re:Imunon, Inc.
Registration Statement on Form S-1
Filed August 29, 2024
File No. 333-281834
Dear Michael H. Tardugno:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Daniel Crawford at 202-551-7767 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:KJ Cho, Esq.

SecProbe.io